The drugs intended to reduce blood pressure, correct arrhythmias and some forms of heart disease are the most commonly prescribed drugs in the US. One in every three adults, or approximately 75 million people, is diagnosed with high blood pressure in the US and many more have pre-hypertension. About 15 million people have some form of irregular heartbeats or arrhythmias. The most commonly prescribed drugs to treat these and other conditions are the so called “channel-blockers” or “agonists” which include calcium, sodium and potassium channel blockers. Worldwide sales of these drugs have reached $6 billion. In the United States, calcium channel blockers are the eighth largest drug class in prescription sales.

The global supplement market is $82 billion, and the US supplement industry contributes $37 billion to that number. Consumers spend billions on dietary supplements trusting in their beneficial effects. Faced with countless options and a worldwide market, choosing supplements can be overwhelming. Rarely are consumers supplied with sufficient scientific information to base their decisions on and usually they only have a company’s marketing materials. Dr. Rath Research Institute conducts academic research in the area of natural health and provides a scientific basis for the development of unique synergy based micronutrient combinations.